Sameer H Patel1, Bradford J Kim1, Ching-Wei D Tzeng1, Yun Shin Chun1, Claudius Conrad1, Jean-Nicolas Vauthey1, Thomas A Aloia2. 1. Department of Surgical Oncology, Unit 1484, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, FCT 17.6000, Houston, TX, 77230-1402, USA. 2. Department of Surgical Oncology, Unit 1484, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, FCT 17.6000, Houston, TX, 77230-1402, USA. TAAloia@mdanderson.org.
Abstract
BACKGROUND: After hepatectomy, over- and under-resuscitations induce cardiopulmonary complications and acute kidney injury, respectively, leading to significant perioperative morbidity and mortality. Unlike serum chemistries or urine output, serum brain natriuretic peptide (BNP) levels have been shown to accurately reflect current intravascular fluid balance without influence from alterations of hormonal axes. Based on these data, this study was designed to measure the impact of a serum BNP-guided hepatobiliary fluid protocol on the incidence of posthepatectomy cardiopulmonary/renal complications. METHODS: Hepatectomy patients registered in a single-institution American College of Surgeons-National Surgical Quality Improvement Program database between 2011 and 2016 were examined in real time for the development of cardiopulmonary/renal complications and divided into pre- (2011-2013) and postimplementation (2014-2016) of a BNP-guided hepatobiliary fluid protocol groups. In the postimplementation group, maintenance fluids were tapered on a set protocol. Bolus fluids, diuresis, and micro-adjustments in fluid rate were guided by daily BNP values. RESULTS: Four hundred sixty patients underwent hepatectomy in the study period with 251 patients in the pre- and 209 patients in the postprotocol implementation groups. Cardiopulmonary/renal complication rates were 4.0% in the preprotocol group and reduced to 0.9% after initiation of the BNP-guided hepatobiliary fluid protocol (p = 0.04). CONCLUSIONS: Despite low event rates, these data suggest that goal-directed postoperative fluid therapy with the combination of a hepatobiliary fluid protocol and serum BNP-guided volume management is superior to traditional chemistry and bedside volume assessment and can reduce posthepatectomy cardiopulmonary and renal complications.
BACKGROUND: After hepatectomy, over- and under-resuscitations induce cardiopulmonary complications and acute kidney injury, respectively, leading to significant perioperative morbidity and mortality. Unlike serum chemistries or urine output, serum brain natriuretic peptide (BNP) levels have been shown to accurately reflect current intravascular fluid balance without influence from alterations of hormonal axes. Based on these data, this study was designed to measure the impact of a serum BNP-guided hepatobiliary fluid protocol on the incidence of posthepatectomy cardiopulmonary/renal complications. METHODS: Hepatectomy patients registered in a single-institution American College of Surgeons-National Surgical Quality Improvement Program database between 2011 and 2016 were examined in real time for the development of cardiopulmonary/renal complications and divided into pre- (2011-2013) and postimplementation (2014-2016) of a BNP-guided hepatobiliary fluid protocol groups. In the postimplementation group, maintenance fluids were tapered on a set protocol. Bolus fluids, diuresis, and micro-adjustments in fluid rate were guided by daily BNP values. RESULTS: Four hundred sixty patients underwent hepatectomy in the study period with 251 patients in the pre- and 209 patients in the postprotocol implementation groups. Cardiopulmonary/renal complication rates were 4.0% in the preprotocol group and reduced to 0.9% after initiation of the BNP-guided hepatobiliary fluid protocol (p = 0.04). CONCLUSIONS: Despite low event rates, these data suggest that goal-directed postoperative fluid therapy with the combination of a hepatobiliary fluid protocol and serum BNP-guided volume management is superior to traditional chemistry and bedside volume assessment and can reduce posthepatectomy cardiopulmonary and renal complications.
Authors: Don Poldermans; Jeroen J Bax; Eric Boersma; Stefan De Hert; Erik Eeckhout; Gerry Fowkes; Bulent Gorenek; Michael G Hennerici; Bernard Iung; Malte Kelm; Keld Per Kjeldsen; Steen Dalby Kristensen; Jose Lopez-Sendon; Paolo Pelosi; François Philippe; Luc Pierard; Piotr Ponikowski; Jean-Paul Schmid; Olav F M Sellevold; Rosa Sicari; Greet Van den Berghe; Frank Vermassen Journal: Eur Heart J Date: 2009-08-27 Impact factor: 29.983
Authors: Andrew D Shaw; Sean M Bagshaw; Stuart L Goldstein; Lynette A Scherer; Michael Duan; Carol R Schermer; John A Kellum Journal: Ann Surg Date: 2012-05 Impact factor: 12.969
Authors: Reitze N Rodseth; Bruce M Biccard; Yannick Le Manach; Daniel I Sessler; Giovana A Lurati Buse; Lehana Thabane; Robert C Schutt; Daniel Bolliger; Lucio Cagini; Daniela Cardinale; Carol P W Chong; Rong Chu; Miłosław Cnotliwy; Salvatore Di Somma; René Fahrner; Wen Kwang Lim; Elisabeth Mahla; Ramaswamy Manikandan; Francesco Puma; Wook B Pyun; Milan Radović; Sriram Rajagopalan; Stuart Suttie; Thuvaraha Vanniyasingam; William J van Gaal; Marek Waliszek; P J Devereaux Journal: J Am Coll Cardiol Date: 2013-09-26 Impact factor: 24.094
Authors: Reitze N Rodseth; Giovana A Lurati Buse; Daniel Bolliger; Christoph S Burkhart; Brian H Cuthbertson; Simon C Gibson; Elisabeth Mahla; David W Leibowitz; Bruce M Biccard Journal: J Am Coll Cardiol Date: 2011-07-26 Impact factor: 24.094
Authors: Sarah B Fisher; Safia Rafeeq; Ken Hess; Travis E Grotz; Paul Mansfield; Richard Royal; Brian Badgwell; Jason Fleming; Keith Fournier; Gary N Mann Journal: J Surg Oncol Date: 2017-11-28 Impact factor: 3.454
Authors: Ryan W Day; Kristoffer W Brudvik; Jean-Nicolas Vauthey; Claudius Conrad; Vijaya Gottumukkala; Yun-Shin Chun; Matthew H Katz; Jason B Fleming; Jeffrey E Lee; Thomas A Aloia Journal: Surgery Date: 2015-11-14 Impact factor: 3.982
Authors: Rebecca K Marcus; Heather A Lillemoe; David C Rice; Gabriel Mena; Brian K Bednarski; Barbra B Speer; Pedro T Ramirez; Javier D Lasala; Neema Navai; Wendell H Williams; Bradford J Kim; Rachel K Voss; Vijaya N Gottumukkala; Thomas A Aloia Journal: Ann Surg Oncol Date: 2019-01-09 Impact factor: 5.344